Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-30

Clinical Trial Update: The Influence of Ezetimibe on Gallbladder Function [NA]

View source ↗

Summary

A clinical trial evaluating the effect of ezetimibe on gallbladder function in chronic acalculous cholecystitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zetia (ezetimibe) (ezetimibe)

Snippet

Sponsor: Indiana University | Conditions: Chronic Acalculous Cholecystitis | NA | Status: WITHDRAWN